Children with biliary atresia who undergo standard Kasai surgery to restore bile flow tend to grow better and have…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
CHOLESTASIS
NewsUrine tests unreliable for pediatric cholestasis screening: Study
Testing for bilirubin, a liver damage marker, in urine is not reliable for screening or diagnosing cholestasis (slowed flow…
ALAGILLE SYNDROME
NewsFirst reported case links Alagille syndrome with biliary atresia
A baby girl with Alagille syndrome and related liver problems that were not responding to standard medication was also…
Lynavoy (linerixibat) is now approved in the U.S. as an oral treatment for cholestatic pruritus, or intense itch due to…
Progressive familial intrahepatic cholestasis type 3 (PFIC3) can cause abnormalities in copper metabolism that mimic another condition, Wilson’s disease,…
Volixibat, Mirum Pharmaceuticals’ experimental oral treatment, may help reduce circulating bile acids and ease itch in pregnant women with…
FATTY LIVER DISEASE
NewsApproval of Kayshild, sold in US as Wegovy, urged in EU for treating MASH
A committee of the European Medicines Agency (EMA) has recommended that Kayshild (semaglutide), marketed in the U.S. and Canada as…
International Alagille Syndrome Awareness Day is tomorrow, Jan. 24, and the advocacy organization Alagille Syndrome Alliance is calling on…
CHOLANGITIS
NewsNew study finds higher cancer risk in PSC with advanced dysplasia
Liver transplant may help prevent bile duct cancer in people with primary sclerosing cholangitis (PSC) who have advanced…
ALAGILLE SYNDROME
NewsMedications known as IBATIs are safe, effective in Alagille: Analysis
Livmarli (maralixibat) and Bylvay (odevixibat) not only offer significant relief from severe itching in children with Alagille…